This Pharmaceutical Company is Ready to Grow

Aileron Therapeutics Inc. (NASDAQ: ALRN) is a bio pharmaceutical company that focuses on the development of novel oncology drugs. The company’s recently developed ALRN-6924 treatment is in Phase 2A clinical trials for the treatment of advanced solid tumors. The company is also developing leukemia treatments which are currently in Phase 1B testing. Analysts have been […]

A Pot Stock With Long Term Potential

Hexo Corp. (NYSE: HEXO) is a Canadian cannabis company that produces adult-use and medical marijuana. The company’s brand is quickly becoming one of the most valuable in the wider industry. Hexo has recently partnered with Molson Coors, a global alcoholic beverage brand, to produce a THC-infused drink that will release in Canada later this month. […]

Wall Street Predicting an Upside for KushCo

KushCo Holdings (OTC: KSHB) is one of many struggling cannabis stocks in what has been a tough year for the industry. However, analysts on Wall Street are predicting a strong upside. Should investors take a risk on this bargain pick while it’s down? If the Wall Street projections are correct, there’s a 227% upside to […]